In October 2020, EVERSANA and NORD teamed up with rare disease experts to brainstorm how to transform the patient journey and create more moments that matter.

Hosted by EVERSANA CEO Jim Lang and moderated by Faruk Abdullah, Senior Managing Director, and Penny Bemus, SVP of Client Management, the group identified numerous solutions for treating the patient holistically and ensuring access to life-altering therapies. A virtual scribe illustrated key messages, themes and ideas discussed throughout their engaging session:

For the 400 million people affected by rare disease, EVERSANA is on a mission to advance the drug development and commercialization of orphan drugs. Together with our clients, we aim to create better patient experiences and bring effective therapies to patients around the world.

Click here to learn about our patient-centered solutions such as clinical trial recruitment platforms, patient engagement and communication, access and affordability solutions, and adherence and nursing support.

Author Team

EVERSANA employs a team of over 2500 professionals across 27 locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter the most to our clients and perform superior services that create value across the product life cycle.